在早产婴儿中阿片类药物的神经发育影响 - 随机和观察性研究的系统审查和元分析
Maya Rakshasbhuvankar1, Chandra Rath2, Sachin Agrawal2
1General Paediatrics, Perth Children's Hospital, Western Australia, Australia; Neonatology, King Edward Memorial Hospital for Women, Perth, Western Australia, Australia.
Early human development
|August 20, 2025
概括
在早产婴儿中使用阿片类药物似乎不会增加神经发育障碍的风险. 然而,证据非常有限,一些研究表明可能对运动能力产生负面影响.
科学领域:
- 新生儿学
- 儿童发育医学
- 药理学
背景情况:
- 在新生儿重症监护室经常给早产婴儿服用阿片类药物来缓解疼痛和痛苦.
- 对于阿片类药物对婴儿神经发育的潜在不良影响存在担忧.
研究的目的:
- 系统地审查随机对照试验 (RCT) 和观察性研究 (OSS),调查阿片类药物对早产婴儿神经发育结果的影响.
主要方法:
- 根据科克伦协作指南进行了系统审查.
- 包括随机对照试验 (RCT) 和观察性研究 (OS).
- 尽可能使用定量综合 (聚合);其他数据使用定性综合.
主要成果:
- 这项审查涉及3173名婴儿的16项研究 (13项OS,3项RCT).
- 没有发现神经发育障碍的风险增加 (证据确定性非常低).
- 在2至3岁的阿片类药物暴露的婴儿中观察到较低的运动分数;定性分析显示阿片类药物的效果可变.
结论:
- 目前关于阿片类药物对早产婴儿神经发育的影响的证据是不确定的.
- 现有证据的确定性被评为"非常低".
相关概念视频
Factors Affecting Drug Response: Overview
2.4K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.4K
Analgesia and Pain Management
788
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
788
Opioid Analgesics: Synthetic and Semisynthetic Opioids
426
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
426
Opioid Analgesics: Morphine and Other Natural Cogeners
361
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
361
Opioid Receptors: Overview
1.8K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
1.8K
Teratogenicity
2.7K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.7K


